Welcome to LookChem.com Sign In|Join Free

CAS

  • or

193153-18-3

Post Buying Request

193153-18-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

193153-18-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 193153-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,1,5 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 193153-18:
(8*1)+(7*9)+(6*3)+(5*1)+(4*5)+(3*3)+(2*1)+(1*8)=133
133 % 10 = 3
So 193153-18-3 is a valid CAS Registry Number.

193153-18-3Relevant articles and documents

From Metal-Organic Framework to Porous Carbon Polyhedron: Toward Highly Reversible Lithium Storage

Peng, Hai-Jun,Hao, Gui-Xia,Chu, Zhao-Hua,Cui, Ying-Lin,Lin, Xiao-Ming,Cai, Yue-Peng

, p. 10007 - 10012 (2017)

By application of a newly designed T-shaped ligand 5-(4-pyridin-4-yl-benzoylamino)isophthalic acid (H2PBAI) to assemble with Zn(II) ions under solvothermal conditions, a novel porous polyhedral metal-organic framework (Zn-PBAI) with pcu topolog

Self-assembled [2]catenane in trapezoidal metallacycles with [Cp?Ir]-corners

Liu, Naifang,Huang, Sheng-Li,Liu, Xiaogang,Luo, He-Kuan,Hor, T. S. Andy

supporting information, p. 12802 - 12805 (2017/12/06)

A series of trapezoidal metallacycles were synthesized by the selective combination of a rigid with a flexible arm. [2]Catenane 3 was obtained by self-assembly when the cavity size of the trapezoidal rings was optimised.

Structural modifications of salicylates: Inhibitors of human CD81-receptor HCV-E2 interaction

Holzer, Marcel,Ziegler, Sigrid,Neugebauer, Alexander,Kronenberger, Bernd,Klein, Christian D.,Hartmann, Rolf W.

experimental part, p. 478 - 484 (2009/04/04)

Starting point of the present paper was the result of a virtual screening using the open conformation of the large extracellular loop (LEL) of the CD81-receptor (crystal structure: PDB-ID: 1G8Q). After benzyl salicylate had been experimentally validated to be a moderate inhibitor of the CD81-LEL-HCV-E2 interaction, further optimization was performed and heterocyclic-substituted benzyl salicylate derivatives were synthesized. The compounds were tested for their ability to inhibit the interaction of a fluorescence-labeled antibody to CD81-LEL using HUH7.5 cells. No compound showed an increase concerning the inhibition of the protein-protein interaction compared to benzyl salicylate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 193153-18-3